Reduction of GnRH and infertility in the R6/2 mouse model of Huntington's disease

被引:58
作者
Papalexi, E
Persson, A
Björkqvist, M
Petersén, Å
Woodman, B
Bates, GP
Sundler, F
Mulder, H
Brundin, P
Popovic, N
机构
[1] Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neuronal Survival Unit, S-22184 Lund, Sweden
[2] Sch Med, Dept Histol & Embryol, Goudi 11527, Greece
[3] Guys Hosp, Div Med & Mol Genet, London SE1 9RT, England
[4] Dept Expt Med Sci, Div Endocrinol Diabet & Metab, S-22184 Lund, Sweden
关键词
hypothalamus; inclusions; infertility; testosterone;
D O I
10.1111/j.1460-9568.2005.04324.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Reductions in testosterone and luteinizing hormone levels and reduced sexual functions have been reported in Huntington's disease (HD) patients. Atrophy of the reproductive organs and loss of fertility have also been observed in the R6/2 mouse, which is currently the most studied transgenic model of HD. In an effort to define the cause of infertility we studied the expression of gonadotropin-releasing hormone (GnRH) in the medial septum, diagonal band of Broca and hypothalamus of R6/2 male mice during sexual maturation. We found a progressive reduction in the numbers of GnRH-immunoreactive neurons in the analysed brain areas of R6/2 mice starting at 5 weeks of age and becoming statistically significant with only 10% of the neurons remaining by 9 weeks of age. Atrophy of testes and seminal vesicles combined with a significant reduction in serum and testicular testosterone levels were detected in 12-week-old R6/2mice. These results suggest that infertility in the R6/2 males is due either to death of GnRH neurons or to a reduction in GnRH expression leading to a downstream impairment of the gonadotropic hormones. Gonadotropic hormone replacement did not mitigate weight loss or restore motor function in R6/2 males.
引用
收藏
页码:1541 / 1546
页数:6
相关论文
共 35 条
[1]   Huntington's disease of the endocrine pancreas: Insulin deficiency and diabetes mellitus due to impaired insulin gene expression [J].
Andreassen, OA ;
Dedeoglu, A ;
Stanojevic, V ;
Hughes, DB ;
Browne, SE ;
Leech, CA ;
Ferrante, RJ ;
Habener, JF ;
Beal, MF ;
Thomas, MK .
NEUROBIOLOGY OF DISEASE, 2002, 11 (03) :410-424
[2]   BRAIN IMMUNOREACTIVE GONADOTROPIN-RELEASING HORMONE IN HUNTINGTONS-CHOREA AND IN NON-CHOREIC SUBJECTS [J].
BIRD, ED ;
CHIAPPA, SA ;
FINK, G .
NATURE, 1976, 260 (5551) :536-538
[3]   The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient β-cell mass and exocytosis [J].
Björkqvist, M ;
Fex, M ;
Renström, E ;
Wierup, N ;
Petersén, Å ;
Gil, J ;
Bacos, K ;
Popovic, N ;
Li, JY ;
Sundler, F ;
Brundin, P ;
Mulder, H .
HUMAN MOLECULAR GENETICS, 2005, 14 (05) :565-574
[4]  
Carter RJ, 1999, J NEUROSCI, V19, P3248
[5]   Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice [J].
Dragatsis, I ;
Levine, MS ;
Zeitlin, S .
NATURE GENETICS, 2000, 26 (03) :300-306
[6]  
FEDOROFF JP, 1994, J NEUROPSYCH CLIN N, V6, P147
[7]   EFFECT OF TESTOSTERONE ON MUSCLE MASS AND MUSCLE PROTEIN-SYNTHESIS [J].
GRIGGS, RC ;
KINGSTON, W ;
JOZEFOWICZ, RF ;
HERR, BE ;
FORBES, G ;
HALLIDAY, D .
JOURNAL OF APPLIED PHYSIOLOGY, 1989, 66 (01) :498-503
[9]  
Gutekunst CA, 1999, J NEUROSCI, V19, P2522
[10]   Standardization and statistical approaches to therapeutic trials in the R6/2 mouse [J].
Hockly, E ;
Woodman, B ;
Mahal, A ;
Lewis, CM ;
Bates, G .
BRAIN RESEARCH BULLETIN, 2003, 61 (05) :469-479